Inhalable development
RELEX Life
- imagine daily health care supplement solution.
Imagine a world where your medicine cabinet of pills and chalky powders is vaporized into a smooth, refreshing breath of Life. Relex Life is your gateway to breathing new life into the health and wellness industry by innovating and funding patent-protected inhalables with Aura Inhale.
your inhalable brand
your idea
RLXI
Develop your own Inhalable
Inhalables are quicker, stronger, and easier to take than traditional pill-based medicine overall. The revolution of healthcare is just beginning, and Aura Inhale has a 20-year patent on the technology behind its vaporization process.
Aura is putting that technology in your hands. What’s the next big thing in inhalable supplements and healthcare? Will you be the genius behind the idea for the next health and wellness best seller? With over a trillion pharmacopia options available, the decision for what’s on the shelves is in Relex Life holders’ hands.
Wellness comes first
Aura Inhale uses technology developed by nuclear chemist Dr. Stephen Boyd to totally revolutionize your medicine cabinet. Ruffle through your bottles of pills and many will have a salt-based molecular delivery method: you’ll find HCl on the bottle. Aura Inhale uses patented technology to deliver the nutrient or medicine directly to the lungs in crystalline form, without using the unhealthy salt-based vehicle.
You’re in charge
Aura Inhale had many possible suitors, but it chose Relex Life because of the special one-to-one investment model RLXI offered. Each new inhalable could be researched and developed separately, and its future would be derived from the creative expertise of the Relex Life holder and Aura Inhale’s team of scientists.
Inhalable Talk
Rlxi tokens
Announcing the Days 1–4 contest winners for the Relex Hunter challenges
The future of medicine and wellness begins today. Relex Life, the only cryptocurrency that allows you to create...
Aura Inhale announces 10 percent RLXI buyback initiative
Inhalable supplement and pharmaceutical company Aura Inhale has announced its plans to reinvest 10 percent of all...